Fraud, manipulation and research misconduct can lead scientists down a slippery slope, affecting drug development, grant funding, and patients’ lives. Scientists working in the field of Alzheimer’s research are under enormous pressure to maintain grant funding, publish, and, ultimately, find a cure. For decades, their primary focus has been preventing or eliminating amyloid plaque in